James C.M. Brust MD
Associate Professor, Medicine, Albert Einstein College of Medicine
Join to View Full Profile
111 E 210th StBronx, NY 10467
Phone+1 718-920-6482
Fax+1 718-561-5165
Dr. Brust is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Infectious Disease, 2005 - 2008
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2001
Certifications & Licensure
- NY State Medical License 2002 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Development and validation of a time-varying correction factor for QT interval assessment in drug-resistant tuberculosis patients.Thanakorn Vongjarudech, Anne-Gaëlle Dosne, Bart Remmerie, Kelly E Dooley, James C M Brust
International Journal of Antimicrobial Agents. 2025-04-01 - 1 citationsCharacteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic ...Anthony J Garcia-Prats, Maria Garcia-Cremades, Vivian Cox, Tamara Kredo, Rory Dunbar
The Lancet. Child & Adolescent Health. 2025-02-01 - 1 citationsThe impact of COVID-19 national lockdowns on drug-resistant tuberculosis in KwaZulu-Natal, South Africa: A spatial analysis.Kristin R V Harrington, Neel R Gandhi, N Sarita Shah, Kogieleum Naidoo, Sara C Auld
Annals of Epidemiology. 2024-09-01
Grant Support
- Therapeutic drug monitoring for linezolid in the treatment of rifampin-resistant tuberculosis: a pragmatic randomized controlled trialALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
- Mentoring of multidisciplinary global health research in tuberculosis and HIVALBERT EINSTEIN COLLEGE OF MEDICINE2020–2026
- Emergence of bedaquiline and clofazimine resistance after interruption of drug-resistant TB therapy in a high HIV prevalence settingALBERT EINSTEIN COLLEGE OF MEDICINE2019–2025
- Integrated, Home-Based Treatment For MDR TB And HIV In Rural South AfricaNational Institute Of Allergy And Infectious Diseases2010–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
